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ABSTRAK
Kebimbangan dan gangguan emosi amat biasa di dalam Penyakit Kecelaruan 
Defisit Perhatian. Laporan kes ini mengetengahkan kes lelaki Melayu berusia 
23 tahun yang menunjukkan masalah memberi perhatian dan kemerosotan 
pencapaian akademiknya secara ketara. Kemerosotan pengajiannya disedari 
oleh ahli keluarganya 2-3 tahun sebelum beliau mendapatkan rawatan psikiatri. 
Beliau juga mengalami masalah kemurungan tetapi  tidak mengalami gejala 
biologi kemurungan. Beliau telah dirawat dengan ubat-ubatan Buproprion 150 mg 
setiap hari dan juga ubat Ritalin 10 mg. Kebiasaannya ubat peransang digunakan 
untuk rawatan penyakit kecelaruan deficit perhatian tetapi dalam kes ini ubat 
anti kemurungan telah digunakan. Beliau telah menunjukkan penambahbaikan 
selepas memakan ubat dan seterusnya dapat memberi fokus kepada pembelajaran 
akademiknya.
Kata kunci: dewasa, kebimbangan, kecelaruan deficit perhatian dan hiperaktif, 
bupropion, tekanan
ABSTRACT
Anxiety and mood symptoms are common in Attention Deficit Disorder. We 
highlight a case of 23-year-old man who presented with poor attention and gradual 
poor academic performance. His poor academic achievement was noted by the 
parent, only for the past 2-3 yrs prior to the psychiatric consultation. He developed 
low mood but there was no biological symptoms of depression. He was started on 
both daily treatment of Buproprion 150 mg daily, and Ritalin 10 mg PRN basis. The 
common treatment for attention deficit disorder in was a stimulant but in this case 
an antidepressant was used. It was shown that patient started to show improvement 
with treatment and was able to focus on his study.
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decline in his study in computer 
science in Europe. The parents noted 
that he was not able to pay attention 
in his class and he spent time playing 
computer games. 
 He was easily distracted by irrelevant 
tasks like playing with his computer 
game while reading his book, bounced 
from one activity to another, or became 
bored quickly. His problem of his mood 
and study was sometimes overlooked 
because they are less overtly disruptive. 
He had symptoms of inattention 
and concentration difficulties which 
included extreme distractibility while 
focusing in his study, struggling to 
complete his reading tasks, tendency to 
overlook details, and leading to errors 
or incomplete work. For the past 2 yrs, 
occasionally he felt low in his mood 
for an episodic period of 2 – 3 months 
because he was not able to focus in his 
study and also absent from his class. 
Sometimes, he was anxious. However, 
he denied any psychopathology 
amounting to a diagnosable entity of 
anxiety and major depressive disorder 
or dysthymia.  
 He was seen by the psychiatrist and 
diagnosed to have ADD and started 
with Buproprion 150 mg daily to control 
his anxiety and mood symptoms. He 
consumed his medication without 
significant side-effects. Fifteen days 
following medication, he subsequently 
felt better. Regarding his task in focusing 
on his study, he was also prescribed 
with Tablet Ritalin 10 mg PRN. After 
Keywords: adult, anxiety, attention deficit hyperactivity disorder (ADHD), bupropion, 
depression
INTRODUCTION
Adult Attention Deficit Disorder 
(ADD) is a relatively common, often 
unrecognized condition. In United 
States, it is estimated to affect about 
4.4% of adult population (Kessler et 
al. 2006). Diagnostic and Statistical 
Manual of Mental Disorders, 5th 
Edition (DSM-5) (American Psychiatric 
Association, 2013) defined ADD 
under ADHD chapter. It define four 
out of the nine ADHD symptoms of 
inattention relating directly to problems 
with organization and planning (i.e. 
loses things, is forgetful, has difficulties 
organizing tasks, and fails to finish 
task. Adults with ADD live with the 
symptoms and suffer effects of the 
illness which attribute to their own 
shortcomings (Brook et al. 2013). 
 Methylphenidate and atomoxetine 
are currently the most prescribed drugs 
for adult ADHD. However, it was found 
that even though it was effective but 
it was not always well tolerated. One 
of proposed alternatives treatment 
for ADHD was the antidepressants, 
particularly those with noradrenergic 
activity (Buoli et al. 2016). There are 
multiple reports on the use of such 
antidepressants for the treatment of 
ADHD in adult populations.
CASE REPORT
A 23-year-old man was referred by 
a general practitioner (GP) for being 
had poor concentration and gradual 
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a month with both daily intake of his 
medication, he felt much better and 
was able to concentrate on his study.
DISCUSSION
This case report highlighted a scenario 
of an adult gentleman who was recently 
diagnosed to have adult attention 
deficit disorder, which was missed 
during the early stage of his life. This 
situation also happens in Europe as 
many cases happen to be never been 
diagnosed or treated when there were 
children (McCarthy et al. 2009). In this 
case, he presented at age of 23 yrs and 
happened to be undiagnosed during 
childhood.
 There were not much difference in 
the diagnosis of ADHD in adult. In this 
case, as inattention was a predominant. 
Patient fullfilled the criteria such as not 
being able to pay or sustaining attention 
to his study, often easily distracted from 
his task, appeared to have tendency 
for incomplete task and possibility of 
leading to error. All these criteria lead 
to the diagnosis of ADHD (Katragadda 
& Schubiner 2007). 
 Anxiety is defined as the feeling of 
being very worried about something that 
may happen or may have happened. A 
person is conscious of the unpleasant 
emotional state of threat or danger 
which can affect one’s behaviour and 
physiological system. Depression is 
defined as feeling of sadness that may 
makes one think that there is no hope 
for the future (Ho et al. 2007). A patient 
suffering from this illness has difficulty 
to complete daily tasks. Prolonged 
untreated causes distress and anxiety 
to the patient. It showed that ADHD in 
adulthood has higher risk to get anxiety 
disorder and depression as it happened 
in this patient (Biederman et al. 2010; 
Schatz & Rostain 2006).
 Treatment in adult ADHD could 
be either pharmacotherapy or non-
pharmacotherapy (Hamedi et al. 2014). 
Patient with ADHD may benefit from 
cognitive behaviour therapy. As in 
pharmacotherapy, a stimulant is often 
chosen as first line of ADHD treatment 
(Epstein et al. 2014; Buoli et al. 2016). 
In this case, patient presented with 
anxiety and mood symptoms which 
was common presentation in adult 
with ADHD (Biederman et al. 2010). 
It is supported that an antidepressant 
showed an evidence to be effective 
in management. Bupropion is one 
of the antidepressants that showed 
effectiveness in treating ADHD with 
comorbid depression and anxiety 
(Daviss et al. 2001; Buoli et al. 2016). It 
is important to identify the symptoms  
CONCLUSION 
Currently there were very limited 
database regarding alternative 
management for adult ADHD. More 
evidence base study were needed to 
prove and explained the effectiveness 
of treatment for ADHD with the used 
of antidepressant. As in this case, the 
outcome proved that Bupropion as an 
antidepressant should be considered 
for pharmacological management 
of adult ADHD especially in case of 
anxiety and depression presenation.
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